BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
38 hedge funds and large institutions have $18.1M invested in Baudax Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-9
Holders Change %
-19.15%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
5
Reduced
16
Closed
24
Calls
$4.14M
Puts
$363K
Net Calls
+$3.78M
Net Calls Change
+$1.69M
Top Buyers
Top Sellers
1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.51M |
2 |
BlackRock
New York
|
-$1.37M |
3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.07M |
4 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$992K |
5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$927K |